Alpinetin Attenuates Persistent Inflammation, Immune Suppression, and Catabolism Syndrome in a Septic Mouse Model

Patients who survive the acute phase of sepsis can progress to persistent inflammation, immunosuppression, and catabolism syndrome (PICS), which usually results in extended recovery periods and multiple complications. Alpinetin is a flavonoid isolated from Alpinia katsumadai Hayata that has been dem...

Full description

Saved in:
Bibliographic Details
Main Authors: Yukun Liu, Kang Wang, Qaunrui Feng, Yongsheng Zhang, Chuntao Wang, Qinxin Liu, Xinghua Liu, Xiang Wang, Wei Gao, Xiangjun Bai, Zhanfei Li, Yuchang Wang
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2021/9998517
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556919434248192
author Yukun Liu
Kang Wang
Qaunrui Feng
Yongsheng Zhang
Chuntao Wang
Qinxin Liu
Xinghua Liu
Xiang Wang
Wei Gao
Xiangjun Bai
Zhanfei Li
Yuchang Wang
author_facet Yukun Liu
Kang Wang
Qaunrui Feng
Yongsheng Zhang
Chuntao Wang
Qinxin Liu
Xinghua Liu
Xiang Wang
Wei Gao
Xiangjun Bai
Zhanfei Li
Yuchang Wang
author_sort Yukun Liu
collection DOAJ
description Patients who survive the acute phase of sepsis can progress to persistent inflammation, immunosuppression, and catabolism syndrome (PICS), which usually results in extended recovery periods and multiple complications. Alpinetin is a flavonoid isolated from Alpinia katsumadai Hayata that has been demonstrated to have anti-inflammatory, antibacterial, and antioxidant activities. The aim of this study was to investigate whether the administration of alpinetin could attenuate PICS in a septic mouse model. Mice were randomly divided into four groups: the (1) sham-operated group, (2) sham+alpinetin (1 mg/kg intravenously infused for once per day after sham operation), (3) cecal ligation and puncture (CLP), and (4) CLP+alpinetin (50 mg/kg intravenously infused for once per day after CLP). Eight days after sham operation or CLP surgery, mice were euthanized for subsequent examination. Alpinetin significantly improved the survival of septic mice. Also, it attenuated the CLP-induced persistent inflammation, immunosuppression, and catabolism syndrome. The level of plasma proinflammatory cytokines and apoptosis of T lymphocytes were obviously decreased by alpinetin as well. Moreover, oxidative stress in the organs was compelling lower in the alpinetin-treated CLP mice. In this clinically relevant model of sepsis, alpinetin ameliorates CLP-induced organ dysfunction and improves the likelihood of survival, possibly through suppressing the inflammatory response, oxidative stress, and apoptosis. These findings suggested that alpinetin could be a potential novel therapeutic approach to prevent sepsis-induced PICS.
format Article
id doaj-art-d592e64a75dd45eba5dafc79d6a0bdc4
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-d592e64a75dd45eba5dafc79d6a0bdc42025-02-03T05:44:08ZengWileyJournal of Immunology Research2314-88612314-71562021-01-01202110.1155/2021/99985179998517Alpinetin Attenuates Persistent Inflammation, Immune Suppression, and Catabolism Syndrome in a Septic Mouse ModelYukun Liu0Kang Wang1Qaunrui Feng2Yongsheng Zhang3Chuntao Wang4Qinxin Liu5Xinghua Liu6Xiang Wang7Wei Gao8Xiangjun Bai9Zhanfei Li10Yuchang Wang11Department of Plastic Surgery, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaDigestive Disease Center, Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, ChinaTrauma Center/Department of Emergency and Traumatic Surgery, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaTrauma Center/Department of Emergency and Traumatic Surgery, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaTrauma Center/Department of Emergency and Traumatic Surgery, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaTrauma Center/Department of Emergency and Traumatic Surgery, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaTrauma Center/Department of Emergency and Traumatic Surgery, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaTrauma Center/Department of Emergency and Traumatic Surgery, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaTrauma Center/Department of Emergency and Traumatic Surgery, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaTrauma Center/Department of Emergency and Traumatic Surgery, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaTrauma Center/Department of Emergency and Traumatic Surgery, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaTrauma Center/Department of Emergency and Traumatic Surgery, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaPatients who survive the acute phase of sepsis can progress to persistent inflammation, immunosuppression, and catabolism syndrome (PICS), which usually results in extended recovery periods and multiple complications. Alpinetin is a flavonoid isolated from Alpinia katsumadai Hayata that has been demonstrated to have anti-inflammatory, antibacterial, and antioxidant activities. The aim of this study was to investigate whether the administration of alpinetin could attenuate PICS in a septic mouse model. Mice were randomly divided into four groups: the (1) sham-operated group, (2) sham+alpinetin (1 mg/kg intravenously infused for once per day after sham operation), (3) cecal ligation and puncture (CLP), and (4) CLP+alpinetin (50 mg/kg intravenously infused for once per day after CLP). Eight days after sham operation or CLP surgery, mice were euthanized for subsequent examination. Alpinetin significantly improved the survival of septic mice. Also, it attenuated the CLP-induced persistent inflammation, immunosuppression, and catabolism syndrome. The level of plasma proinflammatory cytokines and apoptosis of T lymphocytes were obviously decreased by alpinetin as well. Moreover, oxidative stress in the organs was compelling lower in the alpinetin-treated CLP mice. In this clinically relevant model of sepsis, alpinetin ameliorates CLP-induced organ dysfunction and improves the likelihood of survival, possibly through suppressing the inflammatory response, oxidative stress, and apoptosis. These findings suggested that alpinetin could be a potential novel therapeutic approach to prevent sepsis-induced PICS.http://dx.doi.org/10.1155/2021/9998517
spellingShingle Yukun Liu
Kang Wang
Qaunrui Feng
Yongsheng Zhang
Chuntao Wang
Qinxin Liu
Xinghua Liu
Xiang Wang
Wei Gao
Xiangjun Bai
Zhanfei Li
Yuchang Wang
Alpinetin Attenuates Persistent Inflammation, Immune Suppression, and Catabolism Syndrome in a Septic Mouse Model
Journal of Immunology Research
title Alpinetin Attenuates Persistent Inflammation, Immune Suppression, and Catabolism Syndrome in a Septic Mouse Model
title_full Alpinetin Attenuates Persistent Inflammation, Immune Suppression, and Catabolism Syndrome in a Septic Mouse Model
title_fullStr Alpinetin Attenuates Persistent Inflammation, Immune Suppression, and Catabolism Syndrome in a Septic Mouse Model
title_full_unstemmed Alpinetin Attenuates Persistent Inflammation, Immune Suppression, and Catabolism Syndrome in a Septic Mouse Model
title_short Alpinetin Attenuates Persistent Inflammation, Immune Suppression, and Catabolism Syndrome in a Septic Mouse Model
title_sort alpinetin attenuates persistent inflammation immune suppression and catabolism syndrome in a septic mouse model
url http://dx.doi.org/10.1155/2021/9998517
work_keys_str_mv AT yukunliu alpinetinattenuatespersistentinflammationimmunesuppressionandcatabolismsyndromeinasepticmousemodel
AT kangwang alpinetinattenuatespersistentinflammationimmunesuppressionandcatabolismsyndromeinasepticmousemodel
AT qaunruifeng alpinetinattenuatespersistentinflammationimmunesuppressionandcatabolismsyndromeinasepticmousemodel
AT yongshengzhang alpinetinattenuatespersistentinflammationimmunesuppressionandcatabolismsyndromeinasepticmousemodel
AT chuntaowang alpinetinattenuatespersistentinflammationimmunesuppressionandcatabolismsyndromeinasepticmousemodel
AT qinxinliu alpinetinattenuatespersistentinflammationimmunesuppressionandcatabolismsyndromeinasepticmousemodel
AT xinghualiu alpinetinattenuatespersistentinflammationimmunesuppressionandcatabolismsyndromeinasepticmousemodel
AT xiangwang alpinetinattenuatespersistentinflammationimmunesuppressionandcatabolismsyndromeinasepticmousemodel
AT weigao alpinetinattenuatespersistentinflammationimmunesuppressionandcatabolismsyndromeinasepticmousemodel
AT xiangjunbai alpinetinattenuatespersistentinflammationimmunesuppressionandcatabolismsyndromeinasepticmousemodel
AT zhanfeili alpinetinattenuatespersistentinflammationimmunesuppressionandcatabolismsyndromeinasepticmousemodel
AT yuchangwang alpinetinattenuatespersistentinflammationimmunesuppressionandcatabolismsyndromeinasepticmousemodel